Here’s another one I’m not impressed with -
http://www.freerepublic.com/focus/f-news/3864121/posts
US bets on untested company to deliver COVID-19 vaccine
~~~~~~~~~~~~~~
I suspect it’s the only company not owned in part by Gates/Soros.
“Its injector is not approved by federal health authorities” and by that I suspect it means the FDA and CDC which have let us down spectacularly.
I think this purchase/plan is to be hyper ready for the next bio warfare attempt by China when the current planned-demic goes belly up. China has an inventory and they didn’t use their worst stuff.
Then guard the stockpile like life depends on it - respond with unparalleled speed should China do what China does.
The vaccine industry is shockingly reckless, according to litigator Robert F. Kennedy. This may be the only detour around the swamp.
March 18, 2020 - 1634 Eastern
New Public-Private Partnership Created to Develop a U.S.-Based High-Speed, Emergency Surge Drug Packaging Solution, Using Mass-Manufacturable Prefilled Syringes with Optional Mobile-Based GPS Tracking and Confirmation
U.S. Government Provides ApiJect Systems America with Award Valued Up To $456 Million to Create RAPID: The Consortium for Rapid Aseptic Packaging of Injectable Drugs
STAMFORD, Conn., March 18, 2020 /PRNewswire/ -- ApiJect Systems America, a public benefit corporation based here, today joined with the U. S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response in announcing the launch of a public-private partnership dedicated to creating a U.S.-based high-speed, high-volume, emergency drug packaging solution, establishing "surge capacity" for mass-manufacturable prefilled syringes.
The new consortium, called RAPID — Rapid Aseptic Packaging of Injectable Drugs — will be created and managed by ApiJect Systems America. Its purpose is to enable the U.S. Strategic National Stockpile (SNS) to fill and finish hundreds of millions of prefilled syringes to respond quickly and effectively to health emergencies such as COVID-19. The RAPID Consortium will build a surge capacity network of up to eight domestic packaging facilities using a well- established, drug-packaging process called Blow-Fill-Seal (BFS). The BFS process, used in sterile manufacturing facilities worldwide, features a high volume, small medical-grade plastic container that holds a prefilled volume of medicines or vaccines. FDA-approved BFS technology is already used to package billions of doses annually for medicines to treat respiratory conditions, rotavirus oral vaccines and more. The RAPID Consortium will combine this well-established BFS technology with an innovative interlocking needle hub. The result is a prefilled syringe that eliminates the inefficiencies and difficulties of packaging medicines in, and drawing medicines from, glass vials using disposable syringes.
In addition, each prefilled syringe has the option to include an NFC chip that incorporates a secure unique ID number. This enables healthcare professionals at the point of care to use an app on their smartphones to verify that the drug being injected is authentic and unexpired. It also enables health authorities to know in real time when and where each dose is injected.
March 25, 2020
Jefferies Financial Group is ponying up $10 million for the effort to build up to eight “surge” fill-finish facilities in the U.S. that could produce hundreds of millions of syringes for emergencies like the COVID-19 outbreak. In addition to seed capital, Jefferies said it is providing expertise to help find investors for the venture announced last week by Health and Human Services.
HHS awarded a $450 million grant to Stamford, Connecticut-based ApiJect to create the system it is calling Rapid Aseptic Packaging of Injectable Drugs. RAPID is intended to enable the Strategic National Stockpile to quickly fill and finish hundreds of millions of prefilled syringes in short order.
“Our support of RAPID puts us right where all leadership companies belong—on the front lines of the war against this global threat,” Jefferies said in a statement attributed to both CEO Rich Handler and President Brian Friedman. “We need to be sure that when therapeutics and vaccines for COVID-19 become available health care professionals have the resources and ability to administer them quickly and effectively on a massive, global scale.”
ApiJect Ltd. was founded in 2015 by social entrepreneur Marc Koska, who had already spent decades working to prevent deaths in developing countries from the reuse of contaminated needles. Koska invented the ApiJect device so it could be used by healthcare workers anywhere. The company describes it as a low-cost “compact, prefilled, single-dose “soft” syringe—manufactured using Blow-Fill-Seal (BFS) technology.” ApiJect uses manufacturing contractors throughout the world to produce them.
Jefferies Group - one of just 17 primary dealers participating in the New York Fed's open-market buying and selling of securities and Treasury auctions and providing market information to the New York Fed - they are well connected.
Not directly connected but in the room - the lies that got the ball rolling.
March 18, 2020 - 1915 Eastern
Following the eventual end of the pandemic, Gates hopes that countries can work together to better prepare for similar situations, including the "need to have the ability to scale up diagnostics, drugs and vaccines very rapidly...the technologies exist to do this well if the right investments are made"; the $100 million his and his wife Melinda’s Gates Foundation donated to fight the coronavirus is focused on those three areas.
•Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, this week said that mass production of a vaccine would likely not occur for another 12-18 months, and Gates concurred, saying that lots of manufacturing will need to be built to provide "billions of vaccines to protect the world" and that the first vaccines, which would "go to healthcare workers and critical workers...could happen before 18 months if everything goes well, but we and Fauci and others are being careful not to promise this when we are not sure."
•A study released this week by Imperial College in the UK stated that even with mitigation, the U.S. could see around 1 million deaths from the coronavirus, but Gates cautioned that "the parameters used in that model were too negative," pointing to China as "the most critical data we have" and that its social distancing approach was "able to reduce the number of cases."